Variability of Gross Tumor Volume Delineation for Stereotactic Body Radiotherapy of the Lung With Tri-60Co Magnetic Resonance Image-Guided Radiotherapy System (ViewRay): A Comparative Study With Magnetic Resonance- and Computed Tomography-Based Target Delineation

Introduction: To evaluate the intra-/interobserver variability of gross target volumes between delineation based on magnetic resonance imaging and computed tomography in patients simulated for stereotactic body radiotherapy for primary lung cancer and lung metastasis. Materials and Methods: Twenty-five patients (27 lesions) who underwent computed tomography and magnetic resonance simulation with the MR-60Co system (ViewRay) were included in the study. Gross target volumes were delineated on the magnetic resonance imaging (GTVMR) and computed tomography (GTVCT) images by 2 radiation oncologists (RO1 and RO2). Volumes of all contours were measured. Levels of intraobserver (GTVMR_RO vs GTVCT_RO) and interobserver (GTVMR_RO1 vs GTVMR_RO2; GTVCT_RO1 vs GTVCT_RO2) agreement were evaluated using the generalized κ statistics and the paired t test. Results: No significant volumetric difference was observed between all 4 comparisons (GTVMR_RO1 vs GTVCT_RO1, GTVMR_RO2 vs GTVCT_RO2, GTVMR_RO1 vs GTVMR_RO2, and GTVCT_RO1 vs GTVCT_RO2; P > .05), with mean volumes of GTVs ranging 5 to 6 cm3. The levels of agreement between those 4 comparisons were all substantial with mean κ values of 0.64, 0.66, 0.74, and 0.63, respectively. However, the interobserver agreement level was significantly higher for GTVCT compared to GTVMR (P <.001). The mean κ values significantly increased in all 4 comparisons for tumors >5 cm3 compared to tumors ≤5 cm3 (all P < .05). Conclusion: No significant differences in volumes between magnetic resonance- and computed tomograpghy-based Gross target volumes were found among 2 ROs. Magnetic resonance-based GTV delineation for lung stereotactic body radiotherapy also demonstrated acceptable interobserver agreement. Tumors >5 cm3 show higher intra-/interobserver agreement compared to tumors <5 cm3. More experience should be accumulated to reduce variability in magnetic resonance-based Gross target volumes delineation in lung stereotactic body radiotherapy.

[1]  S. Korreman,et al.  Interobserver delineation variation in lung tumour stereotactic body radiotherapy. , 2012, The British journal of radiology.

[2]  D. de Ruysscher,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  C. Rübe,et al.  The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer , 2016, PloS one.

[4]  Sasa Mutic,et al.  The ViewRay system: magnetic resonance-guided and controlled radiotherapy. , 2014, Seminars in radiation oncology.

[5]  R. Abrams,et al.  Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. , 2013, International journal of radiation oncology, biology, physics.

[6]  C. Matthiesen,et al.  Gross tumour volume variations in primary non‐small‐cell lung cancer during the course of treatment with stereotactic body radiation therapy , 2014, Journal of medical imaging and radiation oncology.

[7]  Andrew Scarsbrook,et al.  The use of deformable image registration to integrate diagnostic MRI into the radiotherapy planning pathway for head and neck cancer. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  M Oudkerk,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  D. Palma,et al.  Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists , 2017, American journal of clinical oncology.

[10]  B. O'neill,et al.  MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy. , 2009, The British journal of radiology.

[11]  G. Beluffi,et al.  MRI of the lung , 2010, La radiologia medica.

[12]  Geoffrey D. Hugo,et al.  Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning. , 2017, International journal of radiation oncology, biology, physics.

[13]  M. Puderbach,et al.  MRI of the lung (1/3): methods , 2012, Insights into Imaging.

[14]  Bernard Dubray,et al.  Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Carsten Brink,et al.  Deviations in delineated GTV caused by artefacts in 4DCT. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  M. V. van Herk,et al.  Target delineation variability and corresponding margins of peripheral early stage NSCLC treated with stereotactic body radiotherapy. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  H. Menzel,et al.  The International Commission on Radiation Units and Measurements , 2011, Journal of the ICRU.

[18]  Martin F Fast,et al.  MRI-guided lung SBRT: Present and future developments. , 2017, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[19]  E. Weiss,et al.  Target Volume Delineation Variability and the Effect of Contouring Training during Stereotactic Body Radiation Therapy (SBRT) Planning for Lung Cancer , 2014 .

[20]  J. Debatin,et al.  Whole-body MR imaging in 30 seconds with real-time true FISP and a continuously rolling table platform: feasibility study. , 2001, Radiology.

[21]  Philippe Giraud,et al.  Delineation in thoracic oncology: a prospective study of the effect of training on contour variability and dosimetric consequences , 2011, Radiation oncology.

[22]  Michael Bremer,et al.  The delineation of target volumes for radiotherapy of lung cancer patients. , 2009, Radiotherapy and Oncology.

[23]  Joe Y. Chang,et al.  A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). , 2015, International journal of radiation oncology, biology, physics.

[24]  Marcel van Herk,et al.  Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. , 2006, International Journal of Radiation Oncology, Biology, Physics.

[25]  R. Onimaru,et al.  Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. , 2015, International journal of radiation oncology, biology, physics.

[26]  Matthew P. Goetz,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[27]  Sasa Mutic,et al.  Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[28]  62 , 2018, The Devil's Fork.

[29]  Issam El Naqa,et al.  Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. , 2010, International journal of radiation oncology, biology, physics.

[30]  H Shirato,et al.  Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors. , 2001, International journal of radiation oncology, biology, physics.

[31]  M van Herk,et al.  Definition of the prostate in CT and MRI: a multi-observer study. , 1999, International journal of radiation oncology, biology, physics.

[32]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[33]  Jae-Uk Jeong,et al.  Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group , 2015, Radiation Oncology.

[34]  C. Simone,et al.  Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. , 2017, Practical radiation oncology.

[35]  Dirk De Ruysscher,et al.  PET scans in radiotherapy planning of lung cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  Rob H N Tijssen,et al.  Magnetic resonance imaging in precision radiation therapy for lung cancer. , 2017, Translational lung cancer research.